# Padraig McDonnell

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/padraig-mcdonnell
Canonical HTML page: https://getbiobrief.com/entity/padraig-mcdonnell

## Recent coverage (1 stories)

### Agilent Q1 2026: Pharma Resilience Battles Academic Funding Headwinds
2026-02-26 00:37:40 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Agilent reported a 4.4% core revenue growth in Q1 2026, driven by a strong 7% uptick in the pharmaceutical sector despite an 8% decline in academic and government markets. The company is navigating margin pressures from new tariffs while leaning into high-growth areas like GLP-1 manufacturing and CDMO services.
Full story: https://getbiobrief.com/story/agilent-q1-2026-earnings-pharma-vs-academia

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.